Related Experiment Video
Updated: May 22, 2026
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
New technologies for new influenza vaccines
1VaxInnate, 3 Cedarbrook Drive, Cranbury, NJ 08512, USA. alan.shaw@vaxinnate.com
Vaccine
|May 15, 2012
Summary
New influenza vaccines can be developed using modern virology and immunology techniques. These advanced vaccines aim to improve upon older influenza vaccine technologies, especially for elderly individuals.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Current influenza vaccines were developed using 1930s-1960s technology.
- Decades of scientific advancement offer opportunities for improved influenza vaccines.
Purpose of the Study:
- To explore the potential of modern virology and immunology for developing enhanced influenza vaccines.
- To address limitations of existing vaccines, particularly in elderly populations.
Main Methods:
- Leveraging advancements in virology.
- Utilizing new immunological approaches.
- Developing next-generation vaccine platforms.
Main Results:
- Emerging technologies enable the creation of more effective influenza vaccines.
- Potential for improved vaccine performance in all age groups, including the elderly.
Conclusions:
- Modern scientific tools provide a pathway to superior influenza vaccines.
- Future influenza vaccines can overcome the shortcomings of current formulations, enhancing protection, especially for vulnerable populations like the elderly.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...